Skip to main content

Published locations for Dupilumab shows histological and clinical benefit in larger eosinophilic esophagitis cohort

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Dupilumab shows histological and clinical benefit in larger eosinophilic esophagitis cohort

User login

  • Reset your password
  • /content/dupilumab-shows-histological-and-clinical-benefit-larger-eosinophilic-esophagitis-cohort
  • /familypracticenews/article/252440/immunology/dupilumab-shows-histological-and-clinical-benefit
  • /internalmedicinenews/article/252440/immunology/dupilumab-shows-histological-and-clinical-benefit
  • /pediatricnews/article/252440/immunology/dupilumab-shows-histological-and-clinical-benefit-larger
  • /pediatrics/article/252440/immunology/dupilumab-shows-histological-and-clinical-benefit-larger
  • /internalmedicine/article/252440/immunology/dupilumab-shows-histological-and-clinical-benefit-larger
  • /familymedicine/article/252440/immunology/dupilumab-shows-histological-and-clinical-benefit-larger